NewsPBS NewsHourMay 5, 2026United States
How Recent Court Rulings on Abortion Pills Are Shaping the Midterm Elections
Recent federal court rulings regarding access to the abortion medication mifepristone have intensified political debate ahead of the midterm elections. While the Supreme Court has temporarily maintained current access levels, both political parties are adjusting their campaign strategies to address voter concerns over the future of reproductive healthcare.
Read the full story at PBS NewsHourWhy It Matters
The legal status of , a common abortion medication, remains subject to ongoing federal litigation that could restrict or protect access to prescriptions and mail-order delivery for patients nationwide.
Key Facts
- A federal appeals court issued a ruling restricting mail access to mifepristone.
- The Supreme Court issued a temporary stay on the appeals court ruling, maintaining current access to the drug while the case proceeds.
- The FDA is currently conducting a safety review of mifepristone, which anti-abortion groups are pressuring the agency to accelerate.
- SBA Pro-Life America has publicly called for the firing of FDA Commissioner Dr. Marty Makary.
- A KFF poll from late last year indicates approximately two-thirds of Americans oppose a nationwide ban on mifepristone.
- AP-NORC polling suggests two-thirds of U.S. adults believe abortion should be legal in all or most cases.
- Advancing American Freedom is pursuing a lawsuit to force the FDA to release documents regarding mifepristone.
- The Trump administration has previously taken steps to withhold funds from Planned Parenthood and investigate state-regulated insurance coverage of abortion.
Who's Mentioned
personJohn Mize“CEO of Americans United for Life.”personMarc Wheat“General counsel at Advancing American Freedom.”personMarty Makary“FDA Commissioner facing calls for resignation from anti-abortion groups.”personMelania Trump“Announced support for abortion rights in 2024.”organizationFood and Drug Administration“The federal agency conducting a safety review of mifepristone.”personMarjorie Dannenfelser“President of SBA Pro-Life America.”personMini Timmaraju“President and CEO of Reproductive Freedom for All.”otherMifepristone“The abortion medication currently subject to federal court challenges.”personDonald Trump“President whose administration and judicial appointments are central to the curr”organizationSupreme Court“The judicial body currently considering the legality of mifepristone access.”personCelinda Lake“Democratic pollster.”